- AU$39.12m
- AU$38.09m
- AU$15.77m
Brief: Resonance Health Says United States Food & Drug Administration Grants 510(K) Clearance For Liversmart
Australia's Resonance Health soars on FDA approval for medical device
Australia Stock Exchange release from RESONANCE HEALTH : US FDA Clearance for LiverSmart
Australia Stock Exchange release from RESONANCE HEALTH : PRE_NR Ends: 10:15:42
Australia Stock Exchange release from RESONANCE HEALTH : ASO Project New Data
Australia Stock Exchange release from RESONANCE HEALTH : PRE_NR Ends: 10:15:41
Australia Stock Exchange release from RESONANCE HEALTH : PRE_NR Ends: 09:33:31
Australia Stock Exchange release from RESONANCE HEALTH : LiverSmart Submitted to FDA for US Regulatory Clearance
Australia Stock Exchange release from RESONANCE HEALTH : Jobkeeper Announcement
Australia Stock Exchange release from RESONANCE HEALTH : Results of Meeting
Australia Stock Exchange release from RESONANCE HEALTH : Investor Presentation - Positioning for Growth
Australia Stock Exchange release from RESONANCE HEALTH : PRE_NR Ends: 12:12:27
Australia Stock Exchange release from RESONANCE HEALTH : Appointment of CMO - Professor John Olynyk
Australia Stock Exchange release from RESONANCE HEALTH : ASO R&D Project - Filing of Two Patent Applications
Australia Stock Exchange release from RESONANCE HEALTH : PRE_NR Ends: 08:32:07
Brief: Resonance Health Signs Patient Access Agreement With Thalassaemia International Federation
Australia's Resonance Health climbs on LoA to deploy AI tech to thalassaemia patients
Australia Stock Exchange release from RESONANCE HEALTH : Thalassaemia International Federation to Deploy FerriSmart
Australia Stock Exchange release from RESONANCE HEALTH : PRE_NR Ends: 08:35:56